# Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex

> **NCT00298922** · PHASE2 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 45 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00298922
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-10
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2009-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298922, "Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00298922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*